Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial
用户uavrgk6RFqwQ
1个月前
87
10
已完结
1. 系统已在2025-12-11 15:32:47对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S2665-9913(24)00246-7
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2665991324002467
其他信息:
出版社: Elsevier BV
作者: Anca D Askanase; David D'Cruz; Kenneth Kalunian; Joan T Merrill; Sandra V Navarra; Clélia Cahuzac; Peter Cornelisse; Mark J Murphy; Daniel S Strasser; Luba Trokan; Ouali Berkani
